Daiichi Sankyo (4568 JT)

Analysis

Health Care • Japan

Daiichi Sankyo Company, Limited is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.

Refresh

bullish•Daiichi Sankyo

•08 Aug 2026 19:37

Primer: Daiichi Sankyo (4568 JT) - Aug 2026

Daiichi Sankyo is successfully transitioning into a global oncology powerhouse, driven by its industry-leading Antibody-Drug Conjugate (ADC)...

αSK Primers

91 Views

bullish•Daiichi Sankyo

•05 Aug 2026 08:43

Primer: Daiichi Sankyo (4568 JP) - Aug 2026

Daiichi Sankyo is successfully transitioning into a global oncology leader, driven by its innovative and proprietary DXd antibody-drug...

αSK Primers

104 Views

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00